Annual Non Current Assets
$20.29 M
+$10.93 M+116.73%
December 31, 2024
Summary
- As of March 13, 2025, TARS annual long term assets is $20.29 million, with the most recent change of +$10.93 million (+116.73%) on December 31, 2024.
- During the last 3 years, TARS annual non current assets has risen by +$17.33 million (+586.50%).
- TARS annual non current assets is now at all-time high.
Performance
TARS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$20.29 M
+$1.10 M+5.75%
December 31, 2024
Summary
- As of March 13, 2025, TARS quarterly long term assets is $20.29 million, with the most recent change of +$1.10 million (+5.75%) on December 31, 2024.
- Over the past year, TARS quarterly non current assets has increased by +$1.10 million (+5.75%).
- TARS quarterly non current assets is now at all-time high.
Performance
TARS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TARS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.7% | +5.8% |
| 3 y3 years | +586.5% | +586.5% |
| 5 y5 years | +6993.0% | +6993.0% |
TARS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +715.4% | at high | +749.9% |
| 5 y | 5-year | at high | +6993.0% | at high | +6993.0% |
| alltime | all time | at high | >+9999.0% | at high | +6993.0% |
Tarsus Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $356.70 M(+39.3%) | $20.29 M(+5.7%) |
| Sep 2024 | - | $19.18 M(+34.6%) |
| Jun 2024 | - | $14.26 M(+66.7%) |
| Mar 2024 | - | $8.55 M(-8.6%) |
| Dec 2023 | $256.13 M(+13.6%) | $9.36 M(+3.4%) |
| Sep 2023 | - | $9.05 M(+66.1%) |
| Jun 2023 | - | $5.45 M(+112.3%) |
| Mar 2023 | - | $2.57 M(+3.2%) |
| Dec 2022 | $225.38 M | $2.49 M(+4.2%) |
| Sep 2022 | - | $2.39 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.54 M(-6.7%) |
| Mar 2022 | - | $2.73 M(-7.7%) |
| Dec 2021 | $175.95 M(+3.1%) | $2.96 M(-11.1%) |
| Sep 2021 | - | $3.32 M(+30.6%) |
| Jun 2021 | - | $2.55 M(+1.7%) |
| Mar 2021 | - | $2.50 M(+90.1%) |
| Dec 2020 | $170.66 M(+194.1%) | $1.32 M(-57.7%) |
| Sep 2020 | - | $3.11 M(+103.1%) |
| Jun 2020 | - | $1.53 M(+436.0%) |
| Dec 2019 | $58.03 M(+2335.2%) | $286.00 K |
| Dec 2018 | $2.38 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual non current assets year-on-year change?
- What is Tarsus Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly non current assets year-on-year change?
What is Tarsus Pharmaceuticals annual long term assets?
The current annual non current assets of TARS is $20.29 M
What is the all time high annual non current assets for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual long term assets is $20.29 M
What is Tarsus Pharmaceuticals annual non current assets year-on-year change?
Over the past year, TARS annual long term assets has changed by +$10.93 M (+116.73%)
What is Tarsus Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of TARS is $20.29 M
What is the all time high quarterly non current assets for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly long term assets is $20.29 M
What is Tarsus Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, TARS quarterly long term assets has changed by +$1.10 M (+5.75%)